{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:42:51Z","timestamp":1794642171300,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T00:00:00Z","timestamp":1640908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015362","name":"Amicus Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013223","name":"PTC Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013223","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jpeds.2021.12.072","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T10:59:43Z","timestamp":1641293983000},"page":"139-147.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Outcome of Later-Onset Pompe Disease Identified Through Newborn Screening"],"prefix":"10.1016","volume":"244","author":[{"given":"Ni-Chung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Ling","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn L.M.","family":"in 't Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9525-7260","authenticated-orcid":false,"given":"Douglas O.S.","family":"de Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Ju","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.W.M.Pim.","family":"Pijnappel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8802-5728","authenticated-orcid":false,"given":"Yin-Hsiu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2021.12.072_bib1","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3389","article-title":"Glycogen storage disease type II: acid alphaglucosidase (acid maltase) deficiency","author":"Hirschhorn","year":"2001"},{"key":"10.1016\/j.jpeds.2021.12.072_bib2","first-page":"132","article-title":"Recombinant human acid \u03b1-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2021.12.072_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","article-title":"Recombinant human alpha-glucosidase from rabbit milk in Pompe patients","volume":"356","author":"Van den Hout","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2021.12.072_bib4","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1542\/peds.2007-2222","article-title":"Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program","volume":"122","author":"Chien","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2021.12.072_bib5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jpeds.2010.11.053","article-title":"Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening","volume":"158","author":"Chien","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2021.12.072_bib6","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","article-title":"Pompe disease in infants: improving the prognosis by newborn screening and early treatment","volume":"124","author":"Chien","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2021.12.072_bib7","article-title":"Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis","author":"Berli","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.jpeds.2021.12.072_bib8","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s00415-021-10475-z","article-title":"The impact of interrupting enzyme replacement therapy in late-onset Pompe disease","volume":"268","author":"Wenninger","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.jpeds.2021.12.072_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.nmd.2020.12.001","article-title":"Effect of long term enzyme replacement therapy in late onset Pompe disease: a single-centre experience","volume":"31","author":"Papadimas","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jpeds.2021.12.072_bib10","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/humu.23854","article-title":"Extension of the Pompe mutation database by linking disease-associated variants to clinical severity","volume":"40","author":"Nino","year":"2019","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jpeds.2021.12.072_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/humu.24148","article-title":"Update of the Pompe variant database for the prediction of clinical phenotypes: novel disease-associated variants, common sequence variants, and results from newborn screening","volume":"42","author":"de Faria","year":"2021","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jpeds.2021.12.072_bib12","doi-asserted-by":"crossref","first-page":"768.e31","DOI":"10.1111\/ene.13285","article-title":"European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience","volume":"24","author":"van der Ploeg","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jpeds.2021.12.072_bib13","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/ajmg.a.36110","article-title":"Timing of diagnosis of patients with Pompe disease: data from the Pompe registry","volume":"161A","author":"Kishnani","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2021.12.072_bib14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymgme.2011.06.010","article-title":"Rapid progressive course of later-onset Pompe disease in Chinese patients","volume":"104","author":"Yang","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jpeds.2021.12.072_bib15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pediatrneurol.2011.12.010","article-title":"Early pathologic changes and responses to treatment in patients with later-onset Pompe disease","volume":"46","author":"Chien","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jpeds.2021.12.072_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2017.09.008","article-title":"Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G \u201clate-onset\u201d GAA variant","volume":"122","author":"Rairikar","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jpeds.2021.12.072_bib17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ymgme.2009.12.014","article-title":"Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program","volume":"99","author":"Labrousse","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jpeds.2021.12.072_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.21037\/atm.2019.05.47","article-title":"Newborn screening: Taiwanese experience","volume":"7","author":"Chien","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jpeds.2021.12.072_bib19","first-page":"100591","article-title":"Earlier and higher dosing of alglucosidase alfa improve outcomes in patients with infantile-onset Pompe disease: evidence from real-world experiences","volume":"23","author":"Chien","year":"2020","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.jpeds.2021.12.072_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10545-011-9388-3","article-title":"The quick motor function test: a new tool to rate clinical severity and motor function in Pompe patients","volume":"35","author":"van Capelle","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jpeds.2021.12.072_bib21","first-page":"193","article-title":"Six-Minute Walking Test: normal reference values for Taiwanese children and adolescents","volume":"31","author":"Chen","year":"2015","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.jpeds.2021.12.072_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2466-13-49","article-title":"Reference values for the 6-minute walk test in healthy children and adolescents in Switzerland","volume":"13","author":"Ulrich","year":"2013","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jpeds.2021.12.072_bib23","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1038\/mtna.2016.75","article-title":"From cryptic toward canonical pre-mRNA splicing in Pompe disease: a pipeline for the development of antisense oligonucleotides","volume":"5","author":"Bergsma","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jpeds.2021.12.072_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ymgme.2005.10.016","article-title":"A new diagnostic assay for glycogen storage disease type II in mixed leukocytes","volume":"88","author":"Okumiya","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jpeds.2021.12.072_bib25","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1093\/nar\/15.17.7155","article-title":"RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression","volume":"15","author":"Shapiro","year":"1987","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpeds.2021.12.072_bib26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/1066527041410418","article-title":"Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals","volume":"11","author":"Yeo","year":"2004","journal-title":"J Comput Biol"},{"key":"10.1016\/j.jpeds.2021.12.072_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cmb.1997.4.311","article-title":"Improved splice site detection in Genie","volume":"4","author":"Reese","year":"1997","journal-title":"J Comput Biol"},{"key":"10.1016\/j.jpeds.2021.12.072_bib28","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/nar\/29.5.1185","article-title":"GeneSplicer: a new computational method for splice site prediction","volume":"29","author":"Pertea","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpeds.2021.12.072_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pedneo.2013.03.009","article-title":"Pompe disease: early diagnosis and early treatment make a difference","volume":"54","author":"Chien","year":"2013","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.jpeds.2021.12.072_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ijns6020031","article-title":"Newborn screening for Pompe disease","volume":"6","author":"Sawada","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jpeds.2021.12.072_bib31","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1002\/humu.20745","article-title":"Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating","volume":"29","author":"Kroos","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jpeds.2021.12.072_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ijns6010011","article-title":"Lessons learned from Pompe disease newborn screening and follow-up","volume":"6","author":"Klug","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jpeds.2021.12.072_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ijns6010004","article-title":"Newborn screening for Pompe disease in Illinois: experience with 684,290 infants","volume":"6","author":"Burton","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jpeds.2021.12.072_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/ijns6040089","article-title":"Newborn screening for Pompe disease: Pennsylvania experience","volume":"6","author":"Ficicioglu","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jpeds.2021.12.072_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijns6010009","article-title":"The first year experience of newborn screening for Pompe disease in California","volume":"6","author":"Tang","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jpeds.2021.12.072_bib36","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1111\/ene.13730","article-title":"Disease progression in a pre-symptomatically treated patient with juvenile-onset Pompe disease\u2014need for an earlier treatment?","volume":"25","author":"Chien","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jpeds.2021.12.072_bib37","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s10038-019-0603-7","article-title":"Newborn screening for Pompe disease in Japan: report and literature review of mutations in the GAA gene in Japanese and Asian patients","volume":"64","author":"Momosaki","year":"2019","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jpeds.2021.12.072_bib40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.jpeds.2021.12.072_bib41","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s00268-017-3999-2","article-title":"Radiologically determined sarcopenia predicts morbidity and mortality following abdominal surgery: a systematic review and meta-analysis","volume":"41","author":"Jones","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/j.jpeds.2021.12.072_bib42","doi-asserted-by":"crossref","first-page":"615238","DOI":"10.3389\/fgene.2020.615238","article-title":"Pilot study on genetic associations with age-related sarcopenia","volume":"11","author":"Urzi","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.jpeds.2021.12.072_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fnagi.2014.00267","article-title":"Borderlines between sarcopenia and mild late-onset muscle disease","volume":"6","author":"Palmio","year":"2014","journal-title":"Front Aging Neurosci"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347621012798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347621012798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:11:37Z","timestamp":1758359497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347621012798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":41,"alternative-id":["S0022347621012798"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2021.12.072","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of Later-Onset Pompe Disease Identified Through Newborn Screening","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2021.12.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}